TP53 and head and neck squamous cell carcinoma: Enhanced expression of miR-96-5p is shown to promote cell migration but not cell proliferation, in p53-mutant HNSCC cell lines and to drive resistance to radiotherapy and cisplatin-based chemotherapy in vitro (29).